Header links
Intranet
Dona
image/svg+xml Mapa
Contacte

2-Part Seamless Part A (Phase 2)/ Part B (Phase 3) Randomized, DoubleBlind, Placebo-Controlled, Multicenter Study to Evaluate th

2-Part Seamless Part A (Phase 2)/ Part B (Phase 3) Randomized, DoubleBlind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

Obert
  • Codi protocol: 230LE301
  • Codi EudraCT: 2020-000727-40
  • Grup de recerca: Reumatologia
  • Servei: Reumatologia
  • Investigador/a principal:  Cortes Hernandez, Josefina
  • Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Fase: Fase III